Literature DB >> 22318724

Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1.

Matthew W Parker1, Ping Xu, Xiaobo Li, Craig W Vander Kooi.   

Abstract

Neuropilin-1 (Nrp1) is an essential receptor for angiogenesis that binds to VEGF-A. Nrp1 binds directly to VEGF-A with high affinity, but the nature of their selective binding has remained unclear. Nrp1 was initially reported to bind to the exon 7-encoded region of VEGF-A and function as an isoform-specific receptor for VEGF-A(164/165). Recent data have implicated exon 8-encoded residues, which are found in all proangiogenic VEGF-A isoforms, in Nrp binding. We have determined the crystal structure of the exon 7/8-encoded VEGF-A heparin binding domain in complex with the Nrp1-b1 domain. This structure clearly demonstrates that residues from both exons 7 and 8 physically contribute to Nrp1 binding. Using an in vitro binding assay, we have determined the relative contributions of exon 7- and 8-encoded residues. We demonstrate that the exon 8-encoded C-terminal arginine is essential for the interaction of VEGF-A with Nrp1 and mediates high affinity Nrp binding. Exon 7-encoded electronegative residues make additional interactions with the L1 loop of Nrp1. Although otherwise conserved, the primary sequences of Nrp1 and Nrp2 differ significantly in this region. We further show that VEGF-A(164) binds 50-fold more strongly to Nrp1 than Nrp2. Direct repulsion between the electronegative exon 7-encoded residues of the heparin binding domain and the electronegative L1 loop found only in Nrp2 is found to significantly contribute to the observed selectivity. The results reveal the basis for the potent and selective binding of VEGF-A(164) to Nrp1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318724      PMCID: PMC3322888          DOI: 10.1074/jbc.M111.331140

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

2.  Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis.

Authors:  Michael Strong; Michael R Sawaya; Shuishu Wang; Martin Phillips; Duilio Cascio; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-11       Impact factor: 11.205

3.  Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor.

Authors:  Mathew A von Wronski; Natarajan Raju; Radhakrishna Pillai; Nancy J Bogdan; Edmund R Marinelli; Palaniappa Nanjappan; Kondareddiar Ramalingam; Thangavel Arunachalam; Steve Eaton; Karen E Linder; Feng Yan; Sibylle Pochon; Michael F Tweedle; Adrian D Nunn
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

4.  Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165.

Authors:  Chenghua Gu; Brian J Limberg; G Brian Whitaker; Ben Perman; Daniel J Leahy; Jan S Rosenbaum; David D Ginty; Alex L Kolodkin
Journal:  J Biol Chem       Date:  2002-03-08       Impact factor: 5.157

5.  Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.

Authors:  Wei-Ching Liang; Mark S Dennis; Scott Stawicki; Yvan Chanthery; Qi Pan; Yongmei Chen; Charles Eigenbrot; JianPing Yin; Alexander W Koch; Xiumin Wu; Napoleone Ferrara; Anil Bagri; Marc Tessier-Lavigne; Ryan J Watts; Yan Wu
Journal:  J Mol Biol       Date:  2006-11-10       Impact factor: 5.469

6.  Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.

Authors:  Roni Mamluk; Ze'ev Gechtman; Matthew E Kutcher; Nijole Gasiunas; John Gallagher; Michael Klagsbrun
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

7.  Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.

Authors:  T Karpanen; M Egeblad; M J Karkkainen; H Kubo; S Ylä-Herttuala; M Jäättelä; K Alitalo
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

8.  VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.

Authors:  David O Bates; Tai-Gen Cui; Joanne M Doughty; Matthias Winkler; Marto Sugiono; Jacqueline D Shields; Danielle Peat; David Gillatt; Steven J Harper
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

9.  Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.

Authors:  K A Houck; D W Leung; A M Rowland; J Winer; N Ferrara
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

10.  Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling.

Authors:  Haiyan Jia; Azadeh Bagherzadeh; Basil Hartzoulakis; Ashley Jarvis; Marianne Löhr; Shaheda Shaikh; Rehan Aqil; Lili Cheng; Michelle Tickner; Diego Esposito; Richard Harris; Paul C Driscoll; David L Selwood; Ian C Zachary
Journal:  J Biol Chem       Date:  2006-03-02       Impact factor: 5.157

View more
  68 in total

Review 1.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

Review 2.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

3.  Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form.

Authors:  Matthew W Parker; Andrew D Linkugel; Hira Lal Goel; Tingting Wu; Arthur M Mercurio; Craig W Vander Kooi
Journal:  Structure       Date:  2015-03-05       Impact factor: 5.006

4.  Priorities and trends in the study of proteins in eye research, 1924-2014.

Authors:  Richard D Semba; Maggie Lam; Kai Sun; Pingbo Zhang; Debra A Schaumberg; Luigi Ferrucci; Peipei Ping; Jennifer E Van Eyk
Journal:  Proteomics Clin Appl       Date:  2015-09-16       Impact factor: 3.494

5.  Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling.

Authors:  Fabiola Cecchi; Deborah Pajalunga; C Andrew Fowler; Aykut Uren; Daniel C Rabe; Benedetta Peruzzi; Nicholas J Macdonald; Davida K Blackman; Stephen J Stahl; R Andrew Byrd; Donald P Bottaro
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

6.  Mechanistic basis for the potent anti-angiogenic activity of semaphorin 3F.

Authors:  Hou-Fu Guo; Xiaobo Li; Matthew W Parker; Johannes Waltenberger; Patrice M Becker; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2013-10-18       Impact factor: 3.162

Review 7.  Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.

Authors:  Martine Perrot-Applanat; Melanie Di Benedetto
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

8.  Inhibition of Semaphorin3A Promotes Ocular Dominance Plasticity in the Adult Rat Visual Cortex.

Authors:  Elena Maria Boggio; Erich M Ehlert; Leonardo Lupori; Elizabeth B Moloney; Fred De Winter; Craig W Vander Kooi; Laura Baroncelli; Vasilis Mecollari; Bas Blits; James W Fawcett; Joost Verhaagen; Tommaso Pizzorusso
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

9.  Necroptosis-based CRISPR knockout screen reveals Neuropilin-1 as a critical host factor for early stages of murine cytomegalovirus infection.

Authors:  Rebecca K Lane; Hongyan Guo; Amanda D Fisher; Jonathan Diep; Zhao Lai; Yidong Chen; Jason W Upton; Jan Carette; Edward S Mocarski; William J Kaiser
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

10.  Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1.

Authors:  Matthew W Parker; Andrew D Linkugel; Craig W Vander Kooi
Journal:  J Mol Biol       Date:  2013-07-17       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.